University of Leeds
Amyloidogenicity of Rationally-Designed and Naturally-Occurring Sequence Variants of α-Synuclein
Abstract
dc:description.abstractAggregation and amyloid-formation of α-synuclein (αSyn) is central to the pathogenesis of synucleinopathies. Despite decades of research into the mechanisms underlying the behaviour of αSyn, there remains no cure for these diseases. Changes to the amino acid sequence of αSyn can occur naturally, for example in familial Parkinson’s disease, or can be rationally designed to probe changes to the behaviour of the protein. These sequence changes can drastically alter αSyn as an intrinsically disordered protein in solution, as a helical lipid-bound protein, or as a cross-β amyloid fibril. The work presented here first explores a novel variant of αSyn lacking residues 2 to 7, αSynΔN7, which was rationally designed based on in silico predictions of aggregation-prone regions. Experiments are also described that explore three naturally-occurring alternative splicing variants of αSyn. Using thioflavin T assays, the kinetics of amyloid assembly of αSynΔN7 and the alternative splicing variants of αSyn are investigated. Other biophysical methods such as circular dichroism, electron microscopy, and nuclear magnetic resonance are also used to characterise the variants in solution, at the membrane, and in the formation of amyloid fibrils. Finally, experiments in new strains of the Caenorhabditis elegans model organism are used to corroborate findings in vivo. Key findings confirm that the N7 region regulates amyloid formation both with and without lipid membranes, as well as aggregation in vivo. The alternative splicing variants of αSyn exhibit distinct rates of amyloid formation, with deletion of exon 5 increasing the amyloidogenicity in the absence of lipid membranes. In vivo, the variants all display different profiles of aggregation propensity and proteotoxicity. Overall, the work described in this thesis enhances understanding of the regions critical to the aggregation behaviour of αSyn. By integrating these findings, the potential for targeting specific regions of αSyn in the development of novel therapeutics is revealed.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Leeds
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Dewison, Katherine May
- Advisors dc:contributor.advisor
-
- Radford, Sheena E.
- Brockwell, David J.
- ORCID person:identifier.orcid
Rights
- Language dc:language.dcterms_iso639_2
- eng